Cargando…

Mucin-1 and its relation to grade, stage and survival in ovarian carcinoma patients

BACKGROUND: Mucin-1 is known to be over-expressed by various human carcinomas and is shed into the circulation where it can be detected in patient’s serum by specific anti-Mucin-1 antibodies, such as the tumour marker assays CA 15–3 and CA 27.29. The prognostic value of Mucin-1 expression in ovarian...

Descripción completa

Detalles Bibliográficos
Autores principales:	Engelstaedter, Verena, Heublein, Sabine, Schumacher, Anamur Lan, Lenhard, Miriam, Engelstaedter, Helen, Andergassen, Ulrich, Guenthner-Biller, Margit, Kuhn, Christina, Rack, Brigitte, Kupka, Markus, Mayr, Doris, Jeschke, Udo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582552/ https://www.ncbi.nlm.nih.gov/pubmed/23241107 http://dx.doi.org/10.1186/1471-2407-12-600

Ejemplares similares

Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer
por: Lenhard, Miriam, et al.
Publicado: (2012)

Glycodelin A is a prognostic marker to predict poor outcome in advanced stage ovarian cancer patients
por: Scholz, Christoph, et al.
Publicado: (2012)

Her-2/neu expression is a negative prognosticator in ovarian cancer cases that do not express the follicle stimulating hormone receptor (FSHR)
por: Heublein, Sabine, et al.
Publicado: (2013)

The G-Protein Coupled Estrogen Receptor (GPER/GPR30) is a Gonadotropin Receptor Dependent Positive Prognosticator in Ovarian Carcinoma Patients
por: Heublein, Sabine, et al.
Publicado: (2013)

Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival
por: Lenhard, Miriam, et al.
Publicado: (2012)

The G-Protein-Coupled Estrogen Receptor (GPER/GPR30) in Ovarian Granulosa Cell Tumors
por: Heublein, Sabine, et al.
Publicado: (2014)

KRAS, BRAF genotyping reveals genetic heterogeneity of ovarian borderline tumors and associated implants
por: Heublein, Sabine, et al.
Publicado: (2013)

Immunosuppressive Glycodelin A is an independent marker for poor prognosis in endometrial cancer
por: Lenhard, Miriam, et al.
Publicado: (2013)

Multicentric and multifocal versus unifocal breast cancer: differences in the expression of E-cadherin suggest differences in tumor biology
por: Weissenbacher, Tobias, et al.
Publicado: (2013)

Vitamin D receptor, Retinoid X receptor and peroxisome proliferator-activated receptor γ are overexpressed in BRCA1 mutated breast cancer and predict prognosis
por: Heublein, Sabine, et al.
Publicado: (2017)

Thyroid Hormone Receptors Predict Prognosis in BRCA1 Associated Breast Cancer in Opposing Ways
por: Heublein, Sabine, et al.
Publicado: (2015)

The G-Protein-Coupled Estrogen Receptor (GPER) Regulates Trimethylation of Histone H3 at Lysine 4 and Represses Migration and Proliferation of Ovarian Cancer Cells In Vitro
por: Han, Nan, et al.
Publicado: (2021)

G Protein-Coupled Estrogen Receptor Correlates With Dkk2 Expression and Has Prognostic Impact in Ovarian Cancer Patients
por: Fraungruber, Patricia, et al.
Publicado: (2021)

Subcellular Distribution of Thyroid Hormone Receptor Beta in Ovarian Cancer
por: Heublein, Sabine, et al.
Publicado: (2022)

The Role of Glycosylation in Breast Cancer Metastasis and Cancer Control
por: Kölbl, Alexandra C., et al.
Publicado: (2015)

The Significance of Epithelial-to-Mesenchymal Transition for Circulating Tumor Cells
por: Kölbl, Alexandra C., et al.
Publicado: (2016)

Immunoreactivity of the fully humanized therapeutic antibody PankoMab-GEX™ is an independent prognostic marker for breast cancer patients
por: Heublein, Sabine, et al.
Publicado: (2015)

Potential Interplay of the Gatipotuzumab Epitope TA-MUC1 and Estrogen Receptors in Ovarian Cancer
por: Heublein, Sabine, et al.
Publicado: (2019)

Cytoplasmic versus nuclear THR alpha expression determines survival of ovarian cancer patients
por: Ditsch, Nina, et al.
Publicado: (2020)

The Role of PPARs in Placental Immunology: A Systematic Review of the Literature
por: Hutter, Stefan, et al.
Publicado: (2013)

Extracapsular Lymph Node Involvement in Ovarian Carcinoma
por: Heublein, Sabine, et al.
Publicado: (2019)

Thyronamine regulation of TAAR1 expression in breast cancer cells and investigation of its influence on viability and migration
por: Tremmel, Eileen, et al.
Publicado: (2019)

Do signal transduction cascades influence survival in triple-negative breast cancer? A preliminary study
por: Mumm, Jan-Niclas, et al.
Publicado: (2016)

Placental Expression Patterns of Galectin-1, Galectin-2, Galectin-3 and Galectin-13 in Cases of Intrauterine Growth Restriction (IUGR)
por: Hutter, Stefan, et al.
Publicado: (2016)

Detection of Circulating Tumour Cells from Blood of Breast Cancer Patients via RT-qPCR
por: Andergassen, Ulrich, et al.
Publicado: (2013)

Correction: Pre- and posttreatment with hydrogen sulfide prevents ventilator-induced lung injury by limiting inflammation and oxidation
por: Faller, Simone, et al.
Publicado: (2017)

Pre- and posttreatment with hydrogen sulfide prevents ventilator-induced lung injury by limiting inflammation and oxidation
por: Faller, Simone, et al.
Publicado: (2017)

Analysis of Epithelial Growth Factor-Receptor (EGFR) Phosphorylation in Uterine Smooth Muscle Tumors: Correlation to Mucin-1 and Galectin-3 Expression
por: Weissenbacher, Tobias, et al.
Publicado: (2013)

Sevoflurane posttreatment prevents oxidative and inflammatory injury in ventilator-induced lung injury
por: Wagner, Julie, et al.
Publicado: (2018)

Corrigendum to “Hydrogen Sulfide Prevents Formation of Reactive Oxygen Species through PI3K/Akt Signaling and Limits Ventilator-Induced Lung Injury”
por: Spassov, Sashko Georgiev, et al.
Publicado: (2017)

Hydrogen Sulfide Prevents Formation of Reactive Oxygen Species through PI3K/Akt Signaling and Limits Ventilator-Induced Lung Injury
por: Spassov, Sashko Georgiev, et al.
Publicado: (2017)

What Is the Most Effective Empirical Antibiotic Treatment for Early, Delayed, and Late Fracture-Related Infections?
por: Baertl, Susanne, et al.
Publicado: (2022)

Angiogenic cytokines and their influence on circulating tumour cells in sera of patients with the primary diagnosis of breast cancer before treatment
por: Vilsmaier, Theresa, et al.
Publicado: (2016)

The ARID1A, p53 and ß-Catenin statuses are strong prognosticators in clear cell and endometrioid carcinoma of the ovary and the endometrium
por: Heckl, Marlene, et al.
Publicado: (2018)

Glycosyltransferases as Markers for Early Tumorigenesis
por: Andergassen, Ulrich, et al.
Publicado: (2015)

Detection of Tumor Cell-Specific mRNA in the Peripheral Blood of Patients with Breast Cancer—Evaluation of Several Markers with Real-Time Reverse Transcription-PCR
por: Andergassen, Ulrich, et al.
Publicado: (2013)

Overall Survival of Ovarian Cancer Patients Is Determined by Expression of Galectins-8 and -9
por: Schulz, Heiko, et al.
Publicado: (2018)

Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients †
por: Schulz, Heiko, et al.
Publicado: (2017)

M2 Macrophages Infiltrating Epithelial Ovarian Cancer Express MDR1: A Feature That May Account for the Poor Prognosis
por: Badmann, Susann, et al.
Publicado: (2020)

Estrogen Receptor and HER2 Status on Disseminated Tumor Cells and Primary Tumor in Patients with Early Breast Cancer
por: Jäger, Bernadette A.S., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_gm816s1kvj6v76c2o5tvh9icn6